---
title: "Whole-exome sequencing of BRCA-negative breast cancer patients and case–control analyses identify variants associated with breast cancer susceptibility"
collection: publications
permalink: /publication/2022-human-genomics
excerpt: 'To identify novel germline variants associated with breast cancer predisposition, whole-exome sequencing (WES) was performed.'
date: 2022-11-23
venue: 'Human Genomics'
paperurl: 'https://doi.org/10.1186/s40246-022-00435-7'
citation: 'Lee, N. Y., Hum, M., Zihara, S., Wang, L., <ins>Myint, M.K.</ins>, Lim, D. W. T., ... & Lee, A. S., (2022). &quot;Whole-exome sequencing of BRCA-negative breast cancer patients and case–control analyses identify variants associated with breast cancer susceptibility.&quot; <i>Human genomics</i>. 16(1).'
---
For the majority of individuals with early-onset or familial breast cancer referred for genetic testing, the genetic basis of their familial breast cancer remains unexplained. To identify novel germline variants associated with breast cancer predisposition, whole-exome sequencing (WES) was performed.

[Download paper here](https://doi.org/10.1186/s40246-022-00435-7)

Recommended citation: Lee, N. Y., Hum, M., Zihara, S., Wang, L., Myint, M.K., Lim, D. W. T., ... & Lee, A. S., (2022). &quot;Whole-exome sequencing of BRCA-negative breast cancer patients and case–control analyses identify variants associated with breast cancer susceptibility.&quot; <i>Human genomics</i>. 16(1).